RxDoctor Payments Data

Michelle Glorioso, NP

Nurse Practitioner · Jackson, MSNPI 1205498243

Payments from drug & device makers

$4,289in general payments, 2019–2025

Across 269 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Johnson & Johnson$417
  • Pfizer$167
  • UCB, Inc.$161
  • GSK$118
  • plus $227 from 8 others

What the payments were for

  • Food & beverage$4,14297%
  • Education$1473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,289 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$42,800
Medicare patients
408
Services billed
689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab140$1,306,289
Enbrel SureclickEtanercept147$1,151,646
RinvoqUpadacitinib121$861,972
ActharCorticotropin12$627,458
BenlystaBelimumab45$222,166
Enbrel MiniEtanercept26$182,662
Xeljanz XrTofacitinib Citrate31$174,240
Cimzia (2 Pack)Certolizumab Pegol16$90,391
KevzaraSarilumab20$83,918
Evenity (2 Syringes)Romosozumab-Aqqg11$28,475
Hydroxychloroquine Sulfate644$20,791
MethotrexateMethotrexate Sodium600$9,929
Mycophenolate Mofetil59$5,389
Leflunomide56$3,125
Prednisone511$2,836

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$1,712$861,972121 claims
Mallinckrodt Hospital Products Inc.Acthar$16$627,45812 claims
GSKBenlysta$118$222,16645 claims
UCB, Inc.Cimzia (2 Pack)$161$90,39116 claims
AmgenEvenity (2 Syringes)$1,488$28,47511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →